Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -2022/23 parent results

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            115.36          101.21                                
                 (+14.0 pct)                                             
  Operating         18.61           16.72                                
                 (+11.3 pct)                                             
  Recurring         22.46           17.52                                
                 (+28.2 pct)                                             
  Net               16.57           13.04                                
                 (+27.1 pct)                                             
  EPS             72.62 yen       57.14 yen                              
  EPS Diluted     72.42 yen       56.97 yen                              
  Ann Div                         36.00 yen      24.00 yen               
  -Q2 Div         20.00 yen       15.00 yen      12.00 yen               
  -Q4 Div         12.00 yen       21.00 yen      12.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news